Spectrum Equity Amends GoodRx Holdings Stake Filing

TL;DR

Spectrum Equity updated their GoodRx filing, likely a minor ownership tweak.

AI Summary

Spectrum Equity VII, L.P. and its affiliates have amended their Schedule 13D filing for GoodRx Holdings, Inc. as of September 3, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or changes in percentage are not detailed in this excerpt. The filing is an amendment to a previous submission concerning their stake in the company.

Why It Matters

This amendment signals a potential shift in the ownership structure or strategy of a significant investor in GoodRx, which could influence market perception and stock performance.

Risk Assessment

Risk Level: medium — Amendments to 13D filings can indicate changes in investor strategy or significant ownership shifts, which may impact the stock.

Key Players & Entities

• Spectrum Equity VII, L.P. (company) — Filing entity
• GoodRx Holdings, Inc. (company) — Subject company
• SEA VII MANAGEMENT, LLC (company) — Group member
• SPECTRUM VII CO-INVESTMENT FUND, L.P. (company) — Group member
• SPECTRUM VII INVESTMENT MANAGERS FUND, L.P. (company) — Group member
• Carolina A. Picazo (person) — Contact person

FAQ

Key Financial Figures

• $83,922.05 — lass A Common Stock for net proceeds of $83,922.05. Item5. Interest in the Securities of

Filing Documents

• d861715dsc13da.htm (SC 13D/A) — 94KB
• 0001193125-24-212284.txt ( ) — 96KB

of the Schedule 13D is hereby amended to include the following at the end thereof

Item 4 of the Schedule 13D is hereby amended to include the following at the end thereof: On August 29, 2024, SE VII distributed 3,989,323 shares of the Issuers Class A Common Stock pro rata to its limited partners for no consideration (the August 2024 Distribution). Following the August 2024 Distribution, Spectrum VII Co-Investment Fund, L.P. and Spectrum VII Investment Managers Fund, L.P. made open market sales of an aggregate of 10,677 shares of the Issuers Class A Common Stock for net proceeds of $83,922.05. Item5. Interest in the Securities of the Issuer Items 5(a), (b) and (c) of the Schedule 13D is hereby amended and restated as follows: (a) and (b) All such ownership percentages of the securities reported in this Schedule 13D were calculated assuming 128,478,172 Class A Shares outstanding, based upon 98,583,716 Class A Shares outstanding as of July 30, 2024 as reported on the 10-Q, as increased by 3,989,323 Class A Shares distributed in the August 2024 Distribution and as further increased by 25,905,133 Class B Shares held by the Reporting Persons following the August 2024 Distribution. The aggregate 25,905,133 securities reported in this statement, which constitute 20.16% of the outstanding Class A Shares, are held by the Reporting Persons on an as-converted basis as follows: SE VII is the holder of record of 25,835,983 Class A Shares, Spectrum VII Investment Managers Fund is the holder of record of 44,223 Class A Shares, and Spectrum VII Co-Investment Fund is the holder of record of 24,927 Class A Shares. The general partner of SE VII is Spectrum Equity Associates. The general partner of each of Spectrum VII Investment Managers Fund, Spectrum VII Co-Investment Fund and Spectrum Equity Associates is Management LLC. Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Peter T. Jensen, Stephen M. LeSieur, Brian Regan and Michael W. Farrell may be deemed to share voting and dispositive power ove

View Full Filing

View this SC 13D/A filing on SEC EDGAR